SAS Output

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 899 16 835 75 913 152 925
ERLYTX 403 1 52 8 97 27 164
GI 117 2 104 8 97 19 116
GU 363 6 313 41 499 82 499
LEUK 121 1 52 3 37 8 49
LUNG 238 1 52 15 183 34 207
LYMPH 26 1 52 1 12 7 43
MELAN 98 2 104 10 122 21 128
MMYEL 107 1 52 13 158 29 177
OTHER 52 0 0 1 12 2 12
SXQOL 12 1 52 1 12 2 12
Total 2436 32 1668 176 2142 383 2332

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  35 0 0 1 12 35 213
BREAST 314 7 365 30 365 64 390
CCD 1484 37 1931 145 1765 273 1662
LEUK 14 0 0 0 0 1 6
LUNG 627 11 574 40 487 77 469
OTHER 3 0 0 0 0 1 6
PREV 52 1 52 5 61 8 49
SURV 116 1 52 11 134 27 164
SXQOL 4 0 0 0 0 0 0
Total 2649 57 2974 232 2824 486 2959

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  35 0 0 1 12 35 213
BREAST 1213 23 1200 105 1278 216 1315
CCD 1484 37 1931 145 1765 273 1662
ERLYTX 403 1 52 8 97 27 164
GI 117 2 104 8 97 19 116
GU 363 6 313 41 499 82 499
LEUK 135 1 52 3 37 9 55
LUNG 865 12 626 55 670 111 676
LYMPH 26 1 52 1 12 7 43
MELAN 98 2 104 10 122 21 128
MMYEL 107 1 52 13 158 29 177
OTHER 55 0 0 1 12 3 18
PREV 52 1 52 5 61 8 49
SURV 116 1 52 11 134 27 164
SXQOL 16 1 52 1 12 2 12
Total 5085 89 4642 408 4966 869 5291

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 587 10 522 48 584 96 584
ERLYTX 263 1 52 6 73 19 116
GI 89 1 52 7 85 18 110
GU 232 2 104 23 280 51 310
LEUK 84 1 52 3 37 7 43
LUNG 190 1 52 14 170 31 189
LYMPH 24 0 0 0 0 6 37
MELAN 71 1 52 5 61 15 91
MMYEL 100 1 52 13 158 27 164
OTHER 52 0 0 1 12 2 12
SXQOL 12 1 52 1 12 2 12
Total 1704 19 990 121 1472 274 1668

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  35 0 0 1 12 35 213
BREAST 313 6 313 29 353 63 384
CCD 1113 34 1774 122 1485 217 1321
LEUK 14 0 0 0 0 1 6
LUNG 440 10 522 33 402 59 359
OTHER 3 0 0 0 0 1 6
PREV 33 0 0 2 24 4 24
SURV 75 0 0 5 61 12 73
SXQOL 4 0 0 0 0 0 0
Total 2030 50 2609 192 2337 392 2386

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  35 0 0 1 12 35 213
BREAST 937 23 1200 81 986 173 1053
CCD 1118 34 1774 123 1498 219 1333
ERLYTX 263 1 52 6 73 19 116
GI 155 2 104 9 110 29 177
GU 232 2 104 22 268 51 310
LEUK 115 1 52 5 61 12 73
LUNG 630 11 574 47 572 90 548
LYMPH 19 0 0 1 12 5 30
MELAN 71 1 52 5 61 15 91
MMYEL 100 1 52 13 158 27 164
OTHER 56 0 0 1 12 4 24
PREV 33 0 0 2 24 4 24
SURV 80 3 157 8 97 14 85
SXQOL 16 1 52 1 12 2 12
Total 3860 80 4173 325 3956 699 4253

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 666 15 783 64 779 124 755
ERLYTX 355 1 52 6 73 18 110
GI 52 0 0 1 12 2 12
GU 300 6 313 34 414 72 438
LEUK 89 1 52 2 24 6 37
LUNG 153 1 52 5 61 15 91
LYMPH 11 1 52 1 12 4 24
MELAN 92 2 104 10 122 21 128
MMYEL 16 0 0 2 24 6 37
Total 1734 27 1408 125 1521 268 1632

14-DEC-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1371 18 939 99 1205 217 1321
AFFIL 247 4 209 12 146 33 201
CCOP/NCORP 2116 47 2452 202 2459 416 2532
Non-SWOG 1349 18 939 93 1132 201 1224
Total 5083 87 4539 406 4942 867 5278

14-DEC-2018 6:10

STUDIES OPENED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
MELAN S1801 Melan, Adv, Adj vs Neoadj Pembrolizumab 1 Y 06-DEC-18
MELAN S1801 Melan, Adv, Adj vs Neoadj Pembrolizumab 2 Y 06-DEC-18
MELAN S1801 Melan, Adv, Adj vs Neoadj Pembrolizumab 3 Y 06-DEC-18
GI S1815 Biliary, Met/LocAdv, GC+CPT±Nab-paclitaxel 1 Y 03-DEC-18

14-DEC-2018 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 29
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 13
BREAST S1207 Brst,Adj,Endocrine+/-Everolimus 1 10
LUNG A151216 ALCHEMIST0 - screening 1 7
LUNG A151216 ALCHEMIST0 - screening 0 7
BREAST EA1151 Brst, Tomosynthesis Mammographic Screening 1 6
CCD S1417CD Colorectal, Cost Cohort Study 1 6
SURV S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 5
GU A031501 Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 4
LUNG S1400 SCCA,Adv, Biomarker Master 1 4
BREAST S1416 Brst, TNBC/BRCA, Cis+/- ABT-888 1 3
GU S1602 Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 3
GU S1605 Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 3